: 0.82 to 0.92) and robust screening performance, with an area under the curve (AUC) of 0.84 for self-reports and 0.92 for informant reports regarding dementia. While validated in 15 languages across 25 countries, research remains heavily concentrated in Korean Alzheimer's disease (AD) cohorts, with limited evidence for non-AD dementias. Despite these geographical limitations, the SMCQ is a reliable, globally adapted tool for identifying individuals requiring further cognitive assessment. This study received no specific funding and was not preregistered.
Han et al. (Wed,) studied this question.